15 completed, 6 unknown, 2 recruiting, 1 not yet recruiting. 25 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 25 | Completed 15, Unknown 6, Recruiting 2, Not yet recruiting 1, Terminated 1 |
Follow Dong-A ST Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia DA-9701, DA-9701-R, DA-9701 Placebo - Functional Dyspepsia | Phase 4 | Recruiting | Dong-A ST Co., Ltd. | 300 | 2026-08-06 | 2026-08-10 |
| Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes DA-5218, DA-5218-C - Diabete Mellitus | Phase 4 | Not yet recruiting | Dong-A ST Co., Ltd. | 238 | 2025-11-01 | 2025-11-17 |
| Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control DA-2811, Forxiga - Diabetes Mellitus | Phase 4 | Completed | Dong-A ST Co., Ltd. | 231 | 2023-04-25 | 2025-03-14 |
| Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) Clopidogrel treatment group, No antiplatelet or anticoagulant group - Coronary Artery Disease | Phase 4 | Recruiting | Seoul National University Hospital | 11086 | 2023-03-22 | 2025-12-31 |
| Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients DA-2803, DA-2803-R, Placebo of DA-2803 - Hepatitis B | Phase 4 | Completed | Dong-A ST Co., Ltd. | 120 | 2023-03-20 | 2024-10-23 |
| Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women Risedronate Sodium 35 MG [Actonel], Calcium Vitamin D combination - Postmenopausal Osteoporosis | Phase 4 | Completed | Dong-A ST Co., Ltd. | 149 | 2023-01-03 | 2025-08-24 |
| Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy Eupatilin, Rebamipide - Rheumatoid Arthritis, Osteoarthritis | Phase 4 | Unknown | Seoul National University Boramae Hospital | 50 | 2021-06-01 | 2021-05-13 |
| A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin Evogliptin, Dapagliflozin - Bone Diseases, Metabolic, Diabetes Mellitus, Type 2 | Phase 4 | Unknown | Kyung Hee University Hospital at Gangdong | 120 | 2021-02-01 | 2021-01-13 |
| A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg Evogliptin 5mg/Metformin 1000mg - Diabetes Mellitus, Type 2, Renal Disease | Phase 4 | Unknown | Dong-A ST Co., Ltd. | 54 | 2020-12-01 | 2020-12-11 |
| Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases Evogliptin, Pioglitazone - Type2 Diabetes, Non-Alcoholic Fatty Liver Disease | Phase 4 | Completed | Dong-A ST Co., Ltd. | 51 | 2019-04-12 | 2021-04-29 |
| Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis Jublia® - Mild to Moderate Onychomycosis Due to Dermatophyte | Phase 4 | Completed | Dong-A ST Co., Ltd. | 97 | 2017-11-10 | 2021-04-27 |
| The Efficacy and Safety of Udenafil in Patients With Erectile Dysfunction After Bilateral Nerve-sparing Radical Prostatectomy ZYDENA TAB.75mg(Udenafil 75mg), Placebo Oral Tablet - Prostate Cancer With Radical Prostatectomy | Phase 4 | Unknown | Samsung Medical Center | 99 | 2017-05-01 | 2017-05-05 |
| Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN) evogliptin, Linagliptin - Type2 Diabetes | Phase 4 | Completed | Dong-A ST Co., Ltd. | 207 | 2016-09-01 | 2018-07-23 |
| Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease Acetyl-L-Carnitine, Placebo of Acetyl-L-Carnitine - Alzheimer Disease | Phase 4 | Completed | Dong-A ST Co., Ltd. | 265 | 2016-04-01 | 2021-04-14 |
| Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis CELBESTA®, CELEBREX®, CELEBREX® placebo - Rheumatoid Arthritis | Phase 4 | Completed | Dong-A ST Co., Ltd. | 119 | 2015-11-02 | 2020-02-05 |
| Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk Rosuvastatin, Life style modification - Hypertension | Phase 4 | Completed | Asan Medical Center | 96 | 2015-11-01 | 2021-01-13 |
| The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy OROSARTAN® 5/160mg, CODIOVAN® 160/12.5mg - Hypertension | Phase 4 | Completed | Dong-A ST Co., Ltd. | 238 | 2015-03-16 | 2017-04-12 |
| A Study to Evaluate Efficacy and Safety of Glinib in Newly Diagnosed CML Patients 600mg/day of Imatinib, 400mg/day of Imatinib - Chronic Myeloid Leukemia | Phase 4 | Terminated | Dong-A ST Co., Ltd. | 55 | 2014-10-13 | 2018-06-15 |
| Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia Rosuvastatin(Cresnon®), Rosuvastatin(Crestor®) - Hyperlipidemia | Phase 4 | Completed | Dong-A ST Co., Ltd. | 223 | 2014-09-01 | 2015-07-07 |
| Naftopidil 75mg for Improving Clearance of Urinary Stones naftopidil 75mg - Kidney Calculi, Ureter Calculi | Phase 4 | Unknown | Samsung Medical Center | 130 | 2014-02-01 | 2013-12-13 |
Showing 20 of 25. Sign in to see all of them.
Diabetes Mellitus (3) · Arthritis, Rheumatoid (2) · Diabetes Mellitus, Type 2 (2) · Hypertension (2) · Alzheimer Disease (1) · Bone Diseases, Metabolic (1) · Coronary Artery Disease (1) · Depression (1) · Endocrine System Diseases (1) · Enteritis (1) · Hepatitis B (1) · Hyperlipidemias (1) · Kidney Calculi (1) · Kidney Diseases (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)
4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one (4) · DA 9601 (2) · Rosuvastatin Calcium (2) · dapagliflozin (2) · Acetylcarnitine (1) · Anti-Inflammatory Agents, Non-Steroidal (1) · Celecoxib (1) · DA-9701 (1) · Escitalopram (1) · Imatinib Mesylate (1) · Linagliptin (1) · Metformin (1) · Misoprostol (1) · Pioglitazone (1) · Risedronic Acid (1)
South Korea (22)
Kyu Chan Huh, M.D., Ph.D. (2) · Yong Chan Lee, M.D., Ph.D. (2) · Byung Ik Jang, MD (1) · Byung Seok Lee, M.D. (1) · Byung Wan Lee (1) · Changnam Son, MD,PhD (1) · Chul-won Choi, M.D. (1) · Chul-won Jung, M.D. (1) · Dae Hwan Kang, M.D., Ph.D. (1) · Deok Hyun Han, M.D. (1) · Dong Ho Lee, MD (1) · Dong Il Park, M.D., Ph.D. (1) · Dong Soo Han, MD (1) · Duk-yeon Cho, M.D. (1) · Geun Am Song, M.D., Ph.D. (1)
PMID 28012485, PMID 29030421, PMID 29886724, PMID 32023608, PMID 32912058, PMID 42857284